Anderson et al. used the mouse ovarian surface epithelial (MOSE) cancer progression model to study metabolic changes in distinct disease stages, they found citrate synthase activity was increased during the ovarian cancer progression [6], however, the expression of CS in human ovarian tissues was not investigated. Here, CS is linked to ovarian cancer.